New treatments for mitochondrial diseases: update on recent and current clinical trials

08:30 • MITOS7L1 • Clinical trials landscape in primary mitochondrial diseases in the USA: looking into the future > A. Amel KARAA (Boston, Usa) 08:45 • MITOS7L2 • Sonlicromanol in primary mitochondrial disease MELAS spectrum disorders > J. Jan SMEITINK (Beuningen, The Netherlands) 09:00 • MITOS7L3 • Mitochondrial disease clinical trials: experience gained at the London highly specialised service for rare mitochondrial disorders > R. Robert PITCEATHLY (London, Uk) 09:15 • MITOS7L4 • Elamipretide treatment and Barth syndrome: combined data from a phase 2/3 clinical trial and a natural history comparison study > H. Hilary VERNON (Baltimore, Usa) 09:30 • MITOS7L5 • General discussion between the panel and the audience